Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00786032 · ClinicalTrials.gov registry record

A Clinical Demonstration of EEG Brain-computer Interface for ALS Patients

A clinical trial, sponsored by US Department of Veterans Affairs.

Completed
Registry status
27
Enrollment target

NCT00786032 is a clinical trial that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 27 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00786032 has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
27 participants
Enrollment target

Study Summary

The goal of this VA demonstration project is to show that the Brain-computer interface (BCI) technology is a clinically practical and important new communication and control option that can improve the lives of veterans with amyotrophic lateral sclerosis (ALS). The project will test four well-supported hypotheses: (1) that people with ALS who find (or will soon find) conventional assistive technology inadequate can and will use a BCI system for important purposes in their daily lives without close technical oversight, 2) they will continue and even increase this use throughout the period of the study, (3) that BCI use will improve their lives, and 4) BCI will improve the lives of their families and caregivers.

Interventions

  • DEVICE BCI Device

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2011-09
Est. Completion 2014-08

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT00786032

The ClinicalTrials.gov registry entry for NCT00786032 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which BCI Device is the first listed.

NCT00786032 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00786032 about?

NCT00786032 is a clinical study titled "A Clinical Demonstration of EEG Brain-computer Interface for ALS Patients". The goal of this VA demonstration project is to show that the Brain-computer interface (BCI) technology is a clinically practical and important new communication and control option that can improve the lives of veterans with amyotrophic lateral sclerosis (ALS). The project will test four well-suppor...

What is the current status of trial NCT00786032?

This trial is currently completed. The enrollment target is 27 participants. The study started on 2011-09. Estimated completion is 2014-08.

What interventions are being tested in trial NCT00786032?

The interventions under investigation include: BCI Device (DEVICE).

Who is sponsoring clinical trial NCT00786032?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.